Literature DB >> 6382528

Chemotherapy for advanced urothelial cancer.

A Yagoda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6382528

Source DB:  PubMed          Journal:  Semin Urol        ISSN: 0730-9147


× No keyword cloud information.
  8 in total

Review 1.  Cytotoxic chemotherapy for common adult malignancies: "the emperor's new clothes" revisited?

Authors:  J H Kearsley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04

2.  Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trial.

Authors:  R S Witte; J Manola; P A Burch; T Kuzel; E L Weinshel; P J Loehrer
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

Review 3.  Cisplatin: a review of clinical applications and renal toxicity.

Authors:  D T Sleijfer; S Meijer; N H Mulder
Journal:  Pharm Weekbl Sci       Date:  1985-12-13

4.  Phase I/II trial of intravesical methotrexate for superficial bladder tumors.

Authors:  C N Sternberg; A Yagoda; N H Bander; W F Whitmore; J L Huffman; M Fleisher; M Melamed; M P Fanucchi; P Hollander; E D Vaughan
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Cisplatin-based chemotherapy for the treatment of advanced transitional-cell carcinoma of the urinary tract--a preliminary report.

Authors:  M H Lee; M T Chen; K K Chen; A T Lin; Y H Lee; L M Lee; Y M Chang; L S Chang; J M Liu; R K Hsieh
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin chemotherapy for advanced urothelial cancers.

Authors:  T Ogawa; A Gotoh; A Takenaka; I Hara; K Gohji; S Arakawa; O Matsumoto; S Kamidono
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 7.  Update in cancer chemotherapy: genitourinary tract cancer, Part 2: Wilms' tumor and bladder cancer.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1988-02       Impact factor: 1.798

8.  Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor.

Authors:  Y Kondo; M Satoh; N Imura; M Akimoto
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.